Analyzing Stock...
Downloading quotes and generating insights. Please wait.
← Back to Dashboard 📋 NIFTY 500 Baseline 🧪 Backtest Simulator 🔄 Refresh Live Indicators

GLAND NSE Segment

⏱️ Last Scan Run: 2026-10-14 06:49 AM IST

₹3091.1
+29.3 (+0.96%)
⚠️ NOT A TRADE RECOMMENDATION: These stock metrics and intraday signals are algorithmically generated based on quantitative characteristics that may be relevant to trading. Inclusion or analysis does not mean BUY, SELL or HOLD. This drilldown is a starting point for independent research, not a prediction of future price movement. Markets involve substantial risk, and you may lose some or all of your trading capital.

📊 Technical Price Chart

✨ Multi-Timeframe Trading Setup & Insights

Engine: Gemini (gemini-2.5-flash)

Market Analysis Summary:

"GLAND is exhibiting strong bullish momentum across all timeframes, fueled by recent robust Q1 earnings and subsequent broker upgrades, which propelled the stock to a 4-year high. Technically, the stock is in a confirmed uptrend with price trading above all key moving averages, supported by bullish MACD and strong ADX readings. While today's relative strength against Nifty is slightly negative, the stock's absolute price action demonstrates persistent buying interest, particularly evident in the intraday upward drift. The proximity to the 52-week high suggests a potential breakout into new territory."

Intraday (1 Day) BUY
Conviction: 7/10
Rationale: Using intraday checkpoints: Revalidated using checkpoints up to 15:00. The stock shows persistent buying pressure throughout the afternoon, consistently gaining momentum into the close, reflected by positive intraday change from 11:30 to 15:00. Price is above VWAP (₹3076.97) and trending towards its day high (₹3104.0). Despite below-average RVOL, the sustained positive price action and strong broader technicals suggest a potential to push slightly higher or close strongly.
Entry: ₹3085 - ₹3095
SL: ₹3075
Target: ₹3110
Swing (1-6 Mo) BUY
Conviction: 8/10
Rationale: The stock is in a strong uptrend, trading well above its 50D EMA (₹2845.97) with a bullish MACD crossover and robust ADX confirming trend strength. Recent positive Q1 results and broker upgrades have fueled a significant rally, pushing the stock to a 4-year high. While near the upper Bollinger Band, the underlying fundamental catalysts provide strong support for a continuation of the upward momentum over the medium term. A pullback offers a more favorable entry for better risk-reward.
Entry: ₹2970 - ₹3020
SL: ₹2810
Target: ₹3250
Long Term (1+ Yr) BUY
Conviction: 9/10
Rationale: GLAND is demonstrating exceptional long-term strength, trading near its 52-week high (₹3171.0) and significantly above its 200D EMA (₹2370.41), indicating a powerful secular uptrend. Recent strong Q1 results and analyst upgrades serve as compelling fundamental catalysts, affirming the company's growth trajectory and market position. The overall relative strength over the past year and the positive corporate sentiment position GLAND for continued appreciation and potential to establish new all-time highs over a 1+ year horizon.
Entry: Accumulate on dips below ₹2900
SL: ₹2350
Target: ₹3800

Technical Analysis & Overview:

  • Price (₹3091.1) is trading firmly above its VWAP (₹3076.97) and all significant EMAs (9D, 20D, 34D, 50D, 89D, 200D), underscoring a strong and sustained bullish trend. The Supertrend indicator at ₹2814.94 also remains bullish. The stock is currently near the Upper Bollinger Band (₹3118.03), suggesting it is in a zone of strong upward pressure, albeit potentially extended in the very short term.
  • The MACD shows a strong bullish signal with the MACD Line (56.45) well above the Signal Line (44.83) and an expanding positive Histogram (11.62), indicating robust momentum. The ADX (29.85) above 25, coupled with a dominant +DI (26.7) over -DI (11.82), confirms a strong and strengthening trend. RSI(14) at 60.25 and Stochastic %K at 71.93 are in healthy bullish territory, suggesting strong buying interest without being excessively overbought yet.

News & Sentiment Impact:

The recent news headlines are overwhelmingly positive and act as significant catalysts for Gland Pharma's share price. The 'Gland Pharma rallies 12%, stock hits 4-year high post Q1 results' and 'Gland Pharma Jumps 12% on Strong Q1, Broker Upgrades' indicate strong fundamental performance and positive analyst sentiment. These corporate updates provide a solid foundation for the stock's medium to long-term growth prospects, overshadowing any general sector-related concerns. The sentiment strongly supports a continuation of the upward trend, justifying sustained investor interest.

⚡ Intraday Live Validation DETERIORATING

Entry Decision
⛔ AVOID
Position Health
⚠️ AT RISK (Tighten SL)
Session VWAP ₹3076.97
Peak Drawdown from High -0.42%
Intraday 5m EMA9 / EMA20 ₹3092.2 / ₹3089.25
Audit Reason: MOMENTUM_PULLBACK (-0.4% off high / Below 5m EMA9 Rs.3092.20)

⏱️ Intraday Checkpoints Timeline

09:30 +0.07% (1.90x) ⚪ WAIT 🛡️ HOLD
10:00 -0.03% (0.90x) ⚪ WAIT 🛡️ HOLD
10:30 -0.06% (0.65x) ⚪ WAIT 🛡️ HOLD
11:00 +0.02% (0.51x) ⚪ WAIT 🛡️ HOLD
11:30 +0.43% (0.45x) ⚪ WAIT 🛡️ HOLD
12:00 +0.35% (0.41x) ⚪ WAIT 🛡️ HOLD
12:30 +0.49% (0.39x) ⚪ WAIT 🛡️ HOLD
13:00 +0.32% (0.36x) ⚪ WAIT 🛡️ HOLD
13:30 +0.49% (0.33x) ⚪ WAIT 🛡️ HOLD
14:00 +0.60% (0.35x) ⚪ WAIT 🛡️ HOLD
14:30 +0.88% (0.39x) ⛔ AVOID 🛡️ HOLD
15:00 +0.95% (0.42x) ⛔ AVOID 🛡️ HOLD

📊 Price Action Metrics

Open Price ₹3070.0
Day's High ₹3104.0
Day's Low ₹3025.0
VWAP ₹3076.97
Distance from Day's High 0.42%
Distance from Day's Low 2.19%
52-Week High ₹3171.0
52-Week Low ₹1573.6

📈 Volume & Participation

Current Volume 211881
20-Day Avg Volume 431551.7
Relative Volume (RVOL) 0.49x
Nifty 50 Change 1.6%
Relative Strength vs. Nifty -0.65%

🎯 Comprehensive Technical Indicators Matrix Multi-Period SMAs, EMAs, Oscillators, Bands & Real-Time Verdicts

Indicator & Parameters Calculated Value(s) & Multi-Period Signals Verdict & Bias
RSI (14) 60.25 Bullish (55–70)
Average True Range (ATR 14) ₹90.54 (2.93% of Price) Neutral / Normal
Stochastics (14, 3) %K: 71.93 %D: 70.32 Bullish (%K > %D)
StochRSI (14) %K: 62.83 %D: 61.62 Bullish (%K > %D)
ADX (14) & DMI ADX: 29.85 +DI: 26.7 -DI: 11.82 Strong Bullish Trend (+DI)
Ultimate Oscillator (UO) 59.97 Bullish
Rate of Change (ROC 12) & Momentum ROC: 5.78% Momentum (10D): ₹161.2 Bullish (+ROC)
Williams %R (14) -28.07 Bullish
MACD (12, 26, 9) MACD: 56.45 Signal: 44.83 Histogram: 11.62 Bullish (Line > Signal)
Supertrend (10, 3) ₹2814.94 (Bullish) Bullish Trend
Bollinger Bands (20, 2) Upper: ₹3118.03 Mid: ₹2952.13 Lower: ₹2786.24 Bullish (Above Mid)
Parabolic SAR ₹2855.73 Bullish (Price > SAR)
Commodity Channel Index (CCI 20) 130.88 Strong Bullish / Breakout (≥100)
Simple Moving Averages (SMAs) 20D: ₹2952.13 34D: ₹2932.64 50D: ₹2875.99 89D: ₹2659.65 200D: ₹2188.56 Bullish (Price > 20D > 50D)
Exponential Moving Averages (EMAs) 9D: ₹3022.78 20D: ₹2971.81 34D: ₹2916.62 50D: ₹2845.97 89D: ₹2675.09 200D: ₹2370.41 Bullish Stack (Price > 9D > 20D)
TRIX (15) 0.2037% Bullish (>0)

📰 Latest Google News & Corporate Updates

Gland Pharma Limited (GLAND.NS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Publisher: Yahoo! Finance Canada | Published: Fri, 09 Oct 2026 09:59:58
Gland Pharma (NSEI:GLAND) Stock Forecast & Analyst Predictions - Simply Wall Street
Publisher: Simply Wall Street | Published: Fri, 09 Oct 2026 07:00:00
Gland Pharma Share Price fall: sector context and metrics - Univest
Publisher: Univest | Published: Thu, 08 Oct 2026 07:00:00
Gland Pharma rallies 12%, stock hits 4-year high post Q1 results - Business Standard
Publisher: Business Standard | Published: Tue, 11 Aug 2026 07:00:00
Gland Pharma Jumps 12% on Strong Q1, Broker Upgrades - HDFC Sky
Publisher: HDFC Sky | Published: Tue, 11 Aug 2026 07:00:00

📚 Technical Indicator & Strategy Definitions

SMAs (Simple Moving Averages): Arithmetic mean of closing prices over multiple trading periods (20D, 34D, 50D, 89D, 200D). Price trading above the 200-day SMA indicates a long-term secular bull trend, while 20D/50D track short-to-medium term institutional support levels.
EMAs (Exponential Moving Averages): Weighted moving averages placing greater priority on recent price bars (9D, 20D, 34D, 50D, 89D, 200D). A progressive stack (EMA 9 > 20 > 50) confirms robust upward momentum and provides dynamic support during pullbacks.
ADX (Average Directional Index - 14) & DMI: Measures trend strength regardless of direction. An ADX value ≥ 25 confirms a strong trending market. Directional Movement (+DI / -DI) indicates which side is in control: +DI > -DI is bullish (buyers dominant), whereas -DI > +DI indicates bearish seller control.
VWAP (Volume Weighted Average Price): The average price weighted by intraday volume. Used as a benchmark by institutional participants; price trading above VWAP indicates intraday buyer control, while trading below VWAP indicates intraday seller pressure.
RSI (Relative Strength Index - 14) & StochRSI: Momentum oscillator measuring speed and magnitude of price movements (0–100). RSI > 70 is overbought; RSI < 30 is oversold; 50–60 signals bullish continuation. StochRSI applies stochastics to RSI to generate early inflection signals for trend shifts.
MACD (Moving Average Convergence Divergence): Trend-following momentum indicator displaying the spread between the 12 and 26-period EMAs against a 9-period signal line. MACD crossing above Signal is bullish; rising histogram bars signal accelerating upward momentum.
RVOL (Relative Volume Ratio): Compares current session volume against the 20-day historical average. RVOL ≥ 2.0x signals abnormal institutional participation, confirming the validity of breakouts and trend expansions.
Bollinger Bands (20, 2): Statistical volatility bands set ±2 standard deviations around a 20-period SMA. Contracting bandwidth ('squeeze') signals an impending explosive breakout, while price walking the upper band confirms aggressive trend expansion.
ATR (Average True Range - 14): Quantifies absolute market volatility in rupee terms over a 14-period lookback. Essential for setting volatility-adjusted trailing stop-losses, target sizing, and detecting range expansions.
Supertrend (10, 3): Volatility-based trend-following indicator calculated with ATR. Provides clear Bullish (green trailing line below price) or Bearish (red line above price) regimes to manage active trade trailing stops.
Stochastic Oscillator (%K, %D): Locates current closing price relative to the 14-period high-low range. Fast line (%K) crossing above smooth line (%D) in oversold territory (<20) confirms a buy reversal signal; crosses above 80 warn of overbought conditions.
CCI (Commodity Channel Index - 20): Measures price variation relative to its statistical average. CCI crossing above +100 signals strong uptrend breakout; crossing below -100 indicates deep downward momentum; zero-line cross marks cycle shifts.
Parabolic SAR (Stop and Reverse): Trailing stop overlay that follows price acceleration. When dots plot below price, the trend is bullish; a flip above price triggers trailing stop protection.
Williams %R (14) & TRIX (15): Williams %R reflects momentum relative to lookback highs (-20 to 0 overbought, -80 to -100 oversold). TRIX is a triple-smoothed EMA rate-of-change oscillator filtering noise to capture major cyclical momentum waves.
Relative Strength (vs. Nifty): Measures the percentage outperformance or underperformance against the benchmark Nifty 50 Index. Positive values identify leading stocks commanding institutional capital flow.
Intraday Regime & Permission Gates: 4-gate hierarchical risk firewall evaluating intraday structure, volume effort vs result at day highs, ATR peak drawdown, and VWAP integrity to prevent buying into collapsing peaks.
Opportunity Score (0 – 100) & Risk Score (0 – 100): Dual independent quantitative ratings: Opportunity Score (≥75 top-tier setup) evaluates momentum, volume, pattern, sector tailwinds, and RS. Risk Score (<50 preferred) evaluates drawdown history, resistance proximity, and volatility.
Setup Archetypes: Algorithmic classification: Breakout Candidate (near 20D/52W high with expansion), Pullback Continuation (EMA20 retest in uptrend), Momentum Continuation (high RS5D + ATR expansion), and Reversal Candidate (extended mean-reversion).